$2.14
-0.18-7.76%
At close: -
$2.11
-0.03-1.40%
After Hours: Jan 24, 7:31 PM EDT
Comments
Loading...
Marker Therapeutics (MRKR) Forecast
NewsEarningsMarker Therapeutics (MRKR) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestMarker Therapeutics (NASDAQ:MRKR) Stock Quotes, Forecast and News Summary
Marker Therapeutics Stock (NASDAQ: MRKR) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Marker Therapeutics (MRKR) stock?
You can purchase shares of Marker Therapeutics (NASDAQ:MRKR) through any online brokerage.
Who are Marker Therapeutics (MRKR) competitors?
Other companies in Marker Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), HOOKIPA Pharma (NASDAQ:HOOK), Curis (NASDAQ:CRIS), Coeptis Therapeutics (NASDAQ:COEP) and Evaxion Biotech (NASDAQ:EVAX).
What is the forecast, or price target, for Marker Therapeutics (MRKR) stock?
Marker Therapeutics has a consensus price target of $10.00.
What is the current price for Marker Therapeutics (MRKR)?
The stock price for Marker Therapeutics (NASDAQ: MRKR) is $2.11 last updated January 24, 2025 at 7:31 PM EST.
Does Marker Therapeutics (MRKR) pay a dividend?
There are no upcoming dividends for Marker Therapeutics.
When is Marker Therapeutics (NASDAQ:MRKR) reporting earnings?
Marker Therapeutics’s Q4 earnings are confirmed for Tuesday, March 25, 2025.
Is Marker Therapeutics (MRKR) going to split?
There is no upcoming split for Marker Therapeutics.
What sector and industry does Marker Therapeutics (MRKR) operate in?
Marker Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.